293 results on '"Staumont‐Sallé, Delphine"'
Search Results
2. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
3. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab
4. Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis
5. Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis
6. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study
7. Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience
8. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
9. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases
10. Pseudoxanthoma elasticum, a difficult diagnostic in patient with dark skin
11. DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series
12. Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
13. Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis
14. “Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients
15. Initial characteristics and follow-up of patients with a confirmed diagnosis of angiotensin-converting enzyme inhibitors-induced angioedema
16. Syndrome de Stevens-Johnson induit par la lymécycline chez un adolescent de 17 ans : cas clinique et revue de la littérature
17. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis
18. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
19. Clinical profile of pathological urticarial vasculitis: A retrospective study.
20. Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis
21. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial
22. Atopic dermatitis in elderly adults
23. Immunosuppressants as steroid-sparing agents for chronic DRESS: four cases
24. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis
25. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis
26. Automatic quantification method of eosinophilic degranulation in tissues: Application for the study of eosinophilic disorders
27. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
28. Automatic quantification method of eosinophilic degranulation in tissues: application for the study of eosinophilic disorders
29. P-170 - Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome
30. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study
31. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
32. Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80
33. About two cases of possible topical steroid withdrawal reaction
34. Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
35. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
36. ESDR039 - Functional profile of circulating eosinophils in atopic dermatitis
37. Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey
38. 34927 Adverse events associated with dupilumab in the WHO pharmacovigilance
39. Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80
40. Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma
41. Efficacy of combining pulse corticotherapy and methotrexate in alopecia areata: Real‐life evaluation
42. About two cases of possible topical steroid withdrawal reaction
43. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis:pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
44. Patients with Crohnʼs Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab
45. Conduite à tenir devant une hyperéosinophilie.
46. A new epidemic profile for human scabies in a general practice in the city of Tourcoing, northern France
47. Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases
48. Pyoderma gangrenosum developing in a patient treated with dupilumab
49. The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support
50. Caractéristiques en vraie vie et schémas thérapeutiques chez des patients atteints de dermatite atopique en France : résultats de l’enquête de satisfaction et des besoins non-couverts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.